SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-18-095994
Filing Date
2018-03-26
Accepted
2018-03-26 16:34:51
Documents
47
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A d554994d10qa.htm 10-Q/A 273140
2 EX-31.1 d554994dex311.htm EX-31.1 6002
3 EX-32.1 d554994dex321.htm EX-32.1 3304
  Complete submission text file 0001193125-18-095994.txt   2208395

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rxii-20170331.xml EX-101.INS 386245
5 XBRL TAXONOMY EXTENSION SCHEMA rxii-20170331.xsd EX-101.SCH 25240
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxii-20170331_cal.xml EX-101.CAL 36159
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxii-20170331_def.xml EX-101.DEF 112787
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxii-20170331_lab.xml EX-101.LAB 223567
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxii-20170331_pre.xml EX-101.PRE 172441
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36304 | Film No.: 18713097
SIC: 2834 Pharmaceutical Preparations